Eiji Kiyohara

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis

Diego M. Marzese, Richard A. Scolyer, Jamie L. Huynh et al. · Human Molecular Genetics · 2013 · 116 citations · Full text

Epigenetic Change, Genetics, Dna Methylation +16

The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching

Laurent Lessard, Diego M. Marzese, Hongwei Wang et al. · Journal of Investigative Dermatology · 2015 · 107 citations · Full text

Tumor Biology, Genetics, Melanoma +10

Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome

Diego M. Marzese, Jamie L. Huynh, Hajime Hirose et al. · Pigment Cell & Melanoma Research · 2014 · 53 citations · Full text

Genome-Wide Characterization of Circulating Tumor Cells Identifies Novel Prognostic Genomic Alterations in Systemic Melanoma Metastasis

Connie G. Chiu, Yoshitaka Nakamura, Kelly K. Chong et al. · Clinical Chemistry · 2014 · 52 citations · Full text